The ESC Textbook of Heart Failure

Section 1: Universal definition of heart failure
1.1: Andrew JS Coats, Biykem Bozkurt and Petar M. Seferovic: Universal definition of heart failure
Section 2: Epidemiology of heart failure
2.1: Amy Groenewegen, Ivan Milinkovi?, Arno W Hoes, Arend Mosterd, Frans H Rutten: Epidemiology of heart failure
Section 3: Etiology of heart failure
3.1: (Rocco Antonio Montone, Maurizio Volterrani, Jian Zhang and Filippo Crea: Coronary artery disease
3.2: Athanasios Manolis and Yuri Lopatin: Hypertension
3.3: Ana Pardo Sanz, Ivan Milinkovic and Josep Zamorano: Valvular heart disease
3.4.1: Thomas Thum, Stephane Heymans, and Johannes Backs: Genetic basis of cardiomyopathies
3.4.2: Petar M.Seferovic, Biykem Bozkurt, and Marija Polovina: Dilated and hypokinetic non-dilated cardiomyopathy
3.4.3: Perry Elliott, Michel Noutsias and Aris Anastasakis: Hypertrophic cardiomyopathy
3.4.4: Claudio Rapezzi, Alberto Aimo, Ales Linhart, and Andre Keren: Restrictive cardiomyopathy
3.4.5: Cristina Basso, Hugh Calkins and Domenico Corrado: Arrhythmogenic right ventricular cardiomyopathy
3.4.6: Karen Sliwa and Johann Bauersachs: Peripartum cardiomyopathy
3.4.7: Jelena Templin-Ghadri, Michael Würdinger, Johann Bauersachs, and Christian Templin: Takotsubo cardiomyopathy
3.5: Stephane Heymans, Arsen Risti?, Yehuda Adler, and Massimo Imazio: Myocarditis and pericarditis
3.6: Werner Budts and Jolien Roos-Hesselink: Congenital heart disease
3.7: Martin Huelsmann, Jelena Seferovic and Francesco Cosentino: Endocrine and metabolic disorders
3.8: Lina Badimon, Stefan Anker and Stephan von Haehling: Obesity
3.9: Alexander Lyon, Dimitrios Farmakis, Daniela Cardinale and Teresa Lopez Fernandez: Cancer and cancer therapy
3.10: Antonello Gavazzi, Maria Nunes, and Fausto Pinto: Toxins (e.g. alcohol etc.) and infections
Section 4: Prevention of heart failure
4.1: Massimo Piepoli, Maria Benedetta Matrone, Paul Dendale, and Shelley Zieroth: Prevention of heart failure
Section 5: Pathophysiology of heart failure
5.1: (Junjie Xiao, Thomas Thum, Gianluigi Condorelli and Johannes Backs: Molecular and cellular mechanisms
5.2: Edoardo Bertero and Chistoph Maack: Alterations in myocardial metabolism
5.3: Javier Diez Martinez and Hans-Peter Brunner La Rocca: Ventricular remodelling
5.4: Antoni Bayes Gennis and Faiez Zannad: Neurohormonal activation
5.5: Urlich Hofmann, Stefan Frantz and Nikolaos Frangogiannis: Immune-mediated mechanisms
5.6: Stephane Heymans: Inflammation, oxidative stress and endothelial dysfunction
5.7: Alterations in peripheral circulation and renal function (: Alterations in peripheral circulation and renal function
5.8: (Stephan von Haehling and Wolfram Doehner: Systemic adaptations in metabolism and nutritive status
Section 6: Clinical phenotypes of chronic heart failure
6.1: Thomas Luscher, Petar Seferovic, and Brian Halliday: HFrEF
6.2: Adrian Voors, Brenda Moura, Lars Lund and Carolyn Lam: HFmrEF
6.3: Rudolf De Boer, Burkert Pieske, and Barry Borlaug: HFpEF
6.4: Thomas Luscher, Thomas M. Gorter, Susanna Price, Michael Gatzoulis and Anneline Te Riele: Right heart failure
Section 7: Chronic heart failure: diagnostic and prognostic assessment
7.1: Michel Komajda, Piotr Ponikowski, and Evgeny Shlyakhto: Clinical assessment
7.2: Rudolf de Boer, Antioni Bayes Genis and James Januzzi: Biomarkers in diagnostic and prognostic assessment
7.3: Philippe Debonnaire, Victoria Delgado, Thor Edvardsen, Bogdan Popescu, and Jeroen Bax: Echocardiography
7.4: Danilo Neglia and Alessia Gimelli: Nuclear medicine
7.5: Stephan Achenbach and Amina Rakisheva: Cardiac computed tomography
7.6: Anna Baritussio, Noor Sharrack, Sven Plein, and Chiara Bucciarelli-Bucci: Cardiac magnetic resonance
7.7: Luca Moderato, Davide Lazzeroni, Stamatis Adamopoulos, Alain Cohen-Solal and Massimo Piepoli: Cardiopulmonary exercise
7.8: Christian Hamm, Brigit Assmus and Veselin Mitrovic: Cardiac catheterization, invasive imaging and haemodynamic assessment
Section 8: Chronic heart failure: pharmacological management
8.1: Roberto Ferrari, Gabriele Guardigli, and Biykem Bozkurt: Angiotensin converting enzyme inhibitors
8.2: Ileana L. Pina and Magdy Abdelhamid: Angiotensin I receptor blockers
8.3: Petar M. Seferovic, Michele Senni, Marija Polovina and Andrew JS Coats: ARNI
8.4: Daniela Tomasoni, Marianna Adamo, Hiroyuki Tsutsui, and Marco Metra: Beta-blockers
8.5: Bertram Pitt, João Pedro Ferreira and Faiez Zannad: Mineralocorticoid receptor agonists
8.6: Michael Bohm and Michel Komajda: Ivabradine
8.7: Eftihia Polyzogopoulou, Maria Nikolaou, John Parissis and Alexandre Mebazaa: Vasodilators
8.8: Udo Bavendiek and Johann Bauersachs: Digitalis glycosides
8.9: Jeroen Dauw, Stephen Gottlieb and Wifried Mullens: Diuretics
8.10: Jan Biegus, Piotr Ponikowski, and Christoph Maack: Inotropes and inodilators
8.11: Petar M. Seferovic, Francesco Cosentino, Giuseppe Rosano and James Januzzi: SGLT2 inhibitors
8.12: Stefan Agewall, Isabelle van Gelder, and Irene Savelieva: Ancillary pharmacological treatment options
8.13: Giuseppe Rosano, Gerasimos Filippatos, and Randall Starling: New and emerging therapies
Section 9: Chronic heart failure: non-pharmacological management
9.1: Gianluigi Savarese, Cecilia Linde and Kenneth Dickstein: Implantable cardioverter defibrillator
9.2: Pieter Martens, Eva Goncalvesova, and Wilfried Mullens: Cardiac resynchronization therapy
9.3: Felix Schoenrat, Franz-Josef Neumann, Miguel Sousa Uva and Volkmar Falk: Cardiac surgery
9.4: Stefan Orwat, Stefan Anker and Helmut Baumgartner: Valve interventions
9.5: Andrew JS Coats, Piotr P Ponikowski, Maria-Rosa Costanzo and William T. Abraham: Ancillary procedures
9.6: Maurizio Volterrani, Alain Cohen-Solal, Stamatis Adamopulos, Dimitris Miliopoulos, Ferdinando Iellamo, and Massimo Piepoli: Cardiac rehabilitation
Section 10: Acute heart failure
10.1: Ovidiu Chioncel, Gerasimos Filippatos, Alexandre Mebazaa, Veli-Pekka Harjola, and Josep Masip: Acute heart failure: diagnostic and prognostic assessment
10.2: Katerina Fountoulaki, John Parissis, Sean Collins, Mehmet Birhan Yilmaz, and Alexandre Mebazaa: Acute heart failure: management
Section 11: Advanced heart failure
11.1: Tuvia Ben Gal, Mariell Jessup, and Maria-Rosa Costanzo: Advanced heart failure: assessment
11.2: Daniela Tomasoni, Marianna Adamo, and Marco Metra: Advanced heart failure: management
11.3: Mandeep Mehra and Finn Gustafsson: Mechanical circulatory support
11.4: Davor Milicic, Mandeep Mehra, and Randall Starling: Heart transplantation
11.5: Tiny Jaarsma, Donna Fitzsimons, Lisa Hjelmfors, Loreena Hill, Ekaterini Lambrinou, and Anna Strömberg: Palliative care and end-of-life management
Section 12: Comorbidities and clinical conditions
12.1: Pieter Martens and Hans-Peter Brunner-La Rocca: Chronic kidney disease: Clinical Aspects of Chronic Kidney Disease in Heart Failure
12.2: Javed Butler, Wilfried Mullens and Kevin Damman and João Pedro Ferreira: Dyskalaemia
12.3: Josep Masip, Karina Portillo and Mattia Arrigo: Chronic lung disease
12.4: Piergiuseppe Agostoni, Elisabetta Salvioni, Maria Rosa Costanzo, and Andrew JS Coats: Ventilatory Abnormalities and Sleep Disordered Breathing
12.5: Irene M. Lang and Stephan Rosenkranz: Pulmonary hypertension
12.6: Silvia Priori, Alessandro Trancuccio, Alessia Chiara Latini, Carlo Arnò, Deni Kukavica, and Andrea Mazzanti: Cardiac rhythm disorders
12.7: Paulus Kirchhof, Andreas Metzner, Ruben Schleberger and Douglas Packer: Management of atrial fibrillation in heart failure
12.8: Giuseppe Rosano, Javed Butler, Petar M. Seferovi?, Jelena Seferovic and Francesco Cosentino: Diabetes, metabolic syndrome and endocrine disorders
12.9: Giacomo De Luca, Luca Moroni, Alessandro Tomelleri, R Marcolongo, Lorenzo Dagna, Alida LP Caforio, and Marco Matucci-Cerinic: Systemic immune medicated diseases
12.10: Yuri Lopatin and Gianluigi Savarese: Liver and gut dysfunction
12.11: Ewa Jankowska, Piotr Ponikowski, and Stefan Anker: Anaemia and iron deficiency
12.12: Wolfram Doehner, Cristiana Vitale, and Mehmet Birhan Yilmaz: Depression and cognitive impairment
12.13: Alexander Lyon, Dimitrios Farmakis, Rudolf de Boer, and Yuri Belenkov: Cancer
12.14: Johann Bauersachs, Denise Hilfiker-Kleiner and Karen Sliwa: Pregnancy
12.15: Ewa Jankowska, Cristiana Vitale and Dong-Ju Choi: Frailty
Section 13: Self-care and patient education
13.1: Tiny Jaarsma, Loreena Hill, Ekaterini Lambrinou, Anna Stromberg, and Tina Hansen: Self-care and patient education
Section 14: Multidisciplinary approach to heart failure management
14.1: Loreena Hill, Friedrich Koehler, Tiny Jaarsma, Marija Polovina, Katherine McCreary, and Andrew JS Coats: Multidisciplinary approach to heart failure management
Section 15: Clinical trial design and interpretation
15.1: Gianluigi Savarese, Marija Polovina and Gerasimos Filippatos: Clinical trial design and interpretation
Section 16: Digital health in heart failure
16.1: Arvind Singhal and Martin Cowie: Digital health in heart failure
Section 17: Big data in heart failure
17.1: Mamas Mamas and Dipak Kotecha: Big data in heart failure
Section 18: Telemedicine and remote monitoring
18.1: Tarek Bekfani, Friedrich Koehler and William T. Abraham: Telemedicine and remote monitoring